News

NurExone Biologic Inc: New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company") is pleased to announce new preclinical results ...
Onlymyhealth on MSN1h
When Gut Issues Stem From The Spine: Expert Explains Viscerosomatic Reflexes
Most people think of digestive problems as purely gastrointestinal in origin. Bloating, constipation, cramps, or acid reflux; ...
The Manila Times14h
New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model
Using the CatWalk XT system, researchers assessed ExoPTEN’s effect on the animals’ ability to walk. All animals (100%) in the ...